Searched for
GILEAD LIFESCIENCES
A new HIV drug promises 99.9% protection. But it's making Indian health activists wary; Why?The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 lakh, hinderi...- Stock Market Today: Dow Jones tumbles 400 points as US inflation surges to 3%, S&P 500 and Nasdaq also slide amid Fed rate cut concernsStock Market Today saw a sharp decline as the Dow Jones plummeted 400 points following a rise in US Inflation to 3% YoY. The latest CPI dat...
- Zydus aims to launch first new drug in US by early 2026Zydus will enter a competitive field, with an FDA decision on CymaBay's PBC drug due in August. Gilead Sciences announced its acquisition o...
- These are the companies manufacturing COVID-19 drug Remdesivir in India
- Covid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell RemdesivirCipla, Hetero, and Jubilant Lifesciences have signed voluntary licensing agreements with Gilead.
- Will Gilead’s Covid-19 drug lift sustain for Jubilant Life, Cipla?Use of remdesivir is said to reduce hospital stay by 31 per cent to 11 days from 15 days.
- The reason why Indian doctors haven't prescribed Remdesivir yetThe US has given emergency approval to use the antiviral drug for the treatment of critical Covid-19 patients.
- Gilead looks to make Remdesivir available globallyIn India, people familiar with the development said the company is in discussions with Dr Reddy’s Laboratories, Cipla, Jubilant Lifescience...
- Cipla chief Yusuf K Hamied grooms niece & nephew Samina Vaziralli & Kamil Hamied as genext leadersEven as Hamied prepares genext leaders for Cipla, it’s humanitarian face is out to shake up industry by delivering affordable biosimilar dr...
- Cipla teams up with Gilead Lifesciences to make Hepatitis C drug under voluntary licenceOn the face of it, there is nothing wrong with this kind of a deal. Pharma companies ink many such pacts on a regular basis.
- Hetero Labs to produce Gilead's HIV drugs, through Medicines Patent PoolHyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...
- Drug cos to launch anti-Aids medicinePrices of popular anti-Aids medicine Tenofovir could soon fall as several Indian drug companies plan to launch their low-cost versions in t...
- Pharma rivals strike a chord, join hands for product experimentsPharmaceutical companies in India seem to be conducting a few experiments outside their labs too.
Load More
